Society of American Gastrointestinal and Endoscopic Surgeons
10
1
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
20.0%
2 terminated/withdrawn out of 10 trials
75.0%
-11.5% vs industry average
0%
0 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Multicenter Phase II Study of Transanal TME (taTME)
Role: collaborator
Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes
Role: collaborator
Pilot Trial: Postoperative Opioid-free Analgesia
Role: collaborator
The Microbiology of Bariatric Surgery
Role: collaborator
Bone Metabolism After Bariatric Surgery
Role: collaborator
Comparative Ergonomic Analysis of Robotic Versus Laparoscopic Surgery
Role: collaborator
A Mobile Device App to Improve Adherence to an Enhanced Recovery Program for Colorectal Surgery
Role: collaborator
Intestinal Remodeling And Reprogramming of Glucose Metabolism Following Laparoscopic Roux-en-Y Gastric Bypass
Role: collaborator
Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy
Role: collaborator
Multimodal Prehabilitation for Colorectal Surgery
Role: collaborator
All 10 trials loaded